Usa Washington vaccine Coronavirus Usa Washington

Johnson and Johnson covid vaccine shows strong immune response in early trials

Reading now: 258
www.livemint.com

WASHINGTON : The US pharmaceutical and medical device company Johnson and Johnson has developed a vaccine that in the early trials showed a strong immune response to the novel coronavirus with a single dose, an interim report published on the medical website medRxiv revealed."The safety profile and immunogenicity after only a single dose are supportive for further clinical development of [vaccine] Ad26.COV2.S at a dose level of 5x1010 vp, as a potentially protective vaccine against COVID-19," the report said on Friday. "A single dose of Ad26.COV2.S elicited strong humoral responses in the vast majority of vaccine recipients."The Johnson and Johnson vaccine is the fourth in the United States to enter the final phase of clinical.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA